Opioid Users Found a ‘Miracle Drug’ to Help Them Quit. Then the DEA Banned It
Headline as filed by Wired.
Compare coverage — 2 reports
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| Wired | Opioid Users Found a ‘Miracle Drug’ to Help Them Quit. Then the DEA Banned It |
On Reddit and Discord, people addicted to opioids say SR-17018 can remove withdrawal symptoms. Despite its potential, the DEA has placed it in the same category as heroin. |
0m | wired.com | First Page headline | ||
| Ars Technica | The DEA banned a drug some opioid users called a miracle |
Researchers say the Schedule I ban could kill studies of a promising opioid treatment. |
1d | arstechnica.com | Latest |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Coverage analysis
PageNews compared 2 reports of this event against science, health measures. Each score describes the language one report used, not whether it was right.
What this coverage raises
- Unresolved questions 1 of 2 reports
How many of the reports below framed this event in each of those terms, and how strongly. It records what publishers wrote about, not what will happen — PageNews makes no forecast and has no model of any of these.
What each report emphasised
- Ars Technica more uncertainty than the other reports here
Where the reports diverged most
Measured by PageNews from the headline and the publisher’s own summary, not from the full articles. Scores describe word choice and emphasis; the percentage beside each is confidence, which is separate from the score and lower when there was less text to read. How this is measured.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.